WE CAN BE
Always your one-stop partner on pharmaceutical Industry
WHO ARE WE
Unibest is one-stop solution provider through the whole pharamaceutial chain
unibest R&D team are special in Chiral synthesis, we’ve successfully complete the commercial synthesis of Eribulin for 100 steps we have rich experience on synthesis of long-step, high-difficulty, multi-chiral, high-purity compounds, and established chiral asymmetry, high-efficiency catalysis and green chemistry synthetic platform.
Our formula team, BD team and sales team are linked with each stakeholders closely, we’ve provided intermediate and API to TOP 20 pharmaceutical companies in Europe, America, Japan and India for almost 20 years. We are also ready for dosage project management and registration, we hope our service could help you in the whole industrial chain.
Unibest care about our planet, we are using technologies like supercritical, continuous flow on production, auditing production details based on our strict GMP requirements to make sure every production details are sustainable in a high efficiency.
DOSAGE, INTERMEDIATE, API
"All-rounder is here"
We have prepared a one-stop service for you from product development to resource integration.
Help you make a wiser choice for dosage pre-production and registration, dosage trade will be a lot easier.
Our CDMO team completed the commercial synthesis of eribulin in 2019, accumulated rich experience in the synthesis of long-step, high-difficulty, multi-chiral, high-purity compounds in a greener chemical flow.
Targeted and precise link dosage company, help you find your downstream customers faser, our strict auditing will also help you make better manufacturing.
Preparation product import business goes further
As one of the leading enterprises in the internationalization of China& 39;s pharmaceutical industry,Unibestpharmaceut
The world's largest generic drug company, Announce new name——Viatris
November 12,Mylan and Pfizer announce the name of the new company formed by the planned merger of Mylan and Pfizer.
The 16th birthday of Unibest
In the golden autumn of 2019, members of Unibest family gathered together and celebrated the 16th birthday of Unibest .
Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto
The settlement resolves about 25,000 lawsuits, which claimed the companies failed to warn about deadly bleeding episodes caused by the drug.
API China 2017 in Shanghai
API China, taking place from 16-18 May 2017 in Shanghai, China
FDA approves Vosevi for Hepatitis C
Vosevi is a fixed-dose, combination tablet containing two previously approved drugs – sofosbuvir and velpatasvir – and a new drug, voxilaprevir.